FTSE 100 winning streak ends as WPP shares hit lowest level since 1998; ECB holds rates at 2% - business live

London stocks took a breather after a series of recent gains, with WPP experiencing a significant drop following a profit warning. This decline is noteworthy as it reflects broader concerns about market stability and investor confidence, particularly in the advertising sector. The situation highlights the volatility that can arise in financial markets, reminding investors to stay vigilant.

Meta Platforms has received a significant boost as UBS raises its stock price target to $915, citing strong advertising performance. This is great news for investors, as it reflects confidence in Meta's ability to capitalize on the growing digital ad market. With advertising being a key revenue driver, this adjustment could lead to increased investor interest and potentially higher stock prices in the future.

The European Central Bank's decision to keep policy rates unchanged has resulted in minimal movement in Eurozone government bond yields. This stability indicates that the ECB is maintaining its current monetary policy stance, which is significant for investors and the broader economy as it reflects confidence in the ongoing economic recovery.

The European Central Bank has decided to keep interest rates unchanged for the third consecutive meeting, maintaining the deposit rate at 2%. This decision comes as inflation remains stable and the economy shows signs of growth. Analysts had anticipated this move, and the ECB has indicated that future decisions will be made based on incoming data, emphasizing a cautious approach. This is significant as it reflects the bank's strategy to navigate economic conditions carefully.

Martin Sorrell, the founder of WPP, has expressed concerns that artificial intelligence has already surpassed the point where effective government regulation is feasible. He likens this situation to the 'Oppenheimer moment,' suggesting that the rapid development of AI technology poses challenges that may be beyond regulatory control. This perspective is significant as it highlights the urgency for policymakers to address the implications of AI before it becomes even more entrenched in society.

The European Central Bank has decided to keep interest rates steady for the third consecutive meeting, signaling confidence in the current economic climate. With inflation remaining close to the 2% target and the economy showing signs of growth, this decision reflects a stable financial environment that could encourage further investment and consumer spending. It's a positive indicator for both businesses and consumers as they navigate the economic landscape.

The European Central Bank has decided to keep interest rates unchanged for the third consecutive meeting. This decision reflects the bank's cautious approach to economic conditions in the Eurozone, aiming to balance growth and inflation. It matters because stable interest rates can influence borrowing costs for consumers and businesses, impacting overall economic activity.

German inflation has slowed to nearly 2% in October, which is great news for the economy and supports the European Central Bank's stance on maintaining interest rates. This slowdown indicates that price growth is under control, allowing for more stable economic conditions and potentially easing financial pressures on consumers.

Sekisui Chemical has reported record sales for Q2 2025, showcasing its resilience in a challenging profit environment. Despite facing some profit hurdles, the company's strong sales figures indicate robust demand for its products. This positive performance is significant as it reflects the company's ability to navigate market challenges while maintaining a strong outlook for future growth, which is encouraging for investors and stakeholders alike.

Molina Healthcare's stock has reached a 52-week low, dropping to $151.92, which raises concerns among investors about the company's financial health and market position. This decline could impact investor confidence and may lead to further scrutiny of Molina's business strategies and performance in the healthcare sector.

Trevi Therapeutics has reached an all-time high stock price of 11.11 USD, marking a significant milestone for the company. This surge reflects growing investor confidence and interest in Trevi's innovative therapies, which could lead to increased funding and expansion opportunities. Such a performance not only boosts the company's market presence but also highlights the potential for future growth in the biotech sector.

Perrigo Company has seen its stock price drop to a 52-week low of $20.50, raising concerns among investors about the company's financial health and future prospects. This decline is significant as it reflects broader challenges in the market and could impact investor confidence. Understanding the reasons behind this drop is crucial for stakeholders, as it may indicate underlying issues that need to be addressed.

The Senate has successfully passed a bill aimed at nullifying former President Trump's extensive global tariffs affecting over 100 nations, with a close vote of 51-47. This bipartisan effort follows earlier resolutions to repeal tariffs on Canada and Brazil, signaling a significant shift in U.S. trade policy. The move is crucial as it may enhance international trade relations and reduce costs for American consumers and businesses, fostering a more favorable economic environment.

A US judge has expressed skepticism regarding the Trump administration's legal authority to suspend food benefits, raising concerns about the potential impact on millions of Americans who rely on these essential resources. This matter is significant as it highlights the ongoing debate over government support programs and their role in addressing food insecurity, especially during challenging economic times.